ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3053; 2) Community: the network communities that were significantly associated with the response to NSC 3053; 3) Molecule: the relationships between components within communities and NSC 3053; 4) MDR: the compounds that were significantly associated with the NSC 3053.

NSC Compound Enrichment Correlation
NSC 736443 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide 0.0212053315848711 0.40970016
NSC 743694 Null 0.0212053315848711 0.18477861
NSC 1011 P-[[.ALPHA.-(8-HYDROXY-7-QUINOLYL)BENZYL]AMINO]BENZOIC ACID 0.0220292715546634 0.21122437
NSC 102627 Yoshi 864 0.0220292715546634 0.37977137
NSC 11668 N4,N6-bis(3-chlorophenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine 0.0220292715546634 0.14943336
NSC 12150 Decanediamine, N,N'-bis(4-amino-2-methyl-6-quinolinyl)-, dihydrochloride 0.0220292715546634 0.430418
NSC 123139 L-Cysteine, S-[(4-methylphenyl)diphenylmethyl]- (9CI) 0.0220292715546634 0.38297267
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0220292715546634 0.3169663
NSC 357680 BUELLOLIDE 0.0220292715546634 0.3121315
NSC 381866 BAFILOMYCIN DERIV. 0.0220292715546634 0.36899617
Total:171  Current:103    [First] [Prev] [Next] [Last]